Cooper Companies [COO] vs West Pharmaceutical [WST] Detailed Stock Comparison

The Cooper Companies Inc.

NASDAQ
Loading...

West Pharmaceutical Services Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: The Cooper Companies Inc. wins in 8 metrics, West Pharmaceutical Services Inc. wins in 12 metrics, with 0 ties. West Pharmaceutical Services Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric The Cooper Companies Inc. West Pharmaceutical Services Inc. Better
P/E Ratio (TTM) 33.48 40.99 The Cooper Companies Inc.
Price-to-Book Ratio 1.57 6.94 The Cooper Companies Inc.
Debt-to-Equity Ratio 33.20 10.73 West Pharmaceutical Services Inc.
PEG Ratio 1.18 0.74 West Pharmaceutical Services Inc.
EV/EBITDA 14.36 24.63 The Cooper Companies Inc.
Profit Margin (TTM) 9.67% 16.85% West Pharmaceutical Services Inc.
Operating Margin (TTM) 20.78% 21.70% West Pharmaceutical Services Inc.
EBITDA Margin (TTM) 20.78% 21.70% West Pharmaceutical Services Inc.
Return on Equity 4.87% 19.13% West Pharmaceutical Services Inc.
Return on Assets (TTM) 3.64% 11.21% West Pharmaceutical Services Inc.
Free Cash Flow (TTM) $433.70M $468.90M West Pharmaceutical Services Inc.
Dividend Yield N/A 0.46% N/A
1-Year Return -2.61% 48.18% West Pharmaceutical Services Inc.
Price-to-Sales Ratio (TTM) 3.16 6.72 The Cooper Companies Inc.
Enterprise Value $15.78B $21.43B West Pharmaceutical Services Inc.
EV/Revenue Ratio 3.80 6.65 The Cooper Companies Inc.
Gross Profit Margin (TTM) 67.88% 35.08% The Cooper Companies Inc.
Revenue per Share (TTM) $21 $45 West Pharmaceutical Services Inc.
Earnings per Share (Diluted) $2.01 $7.47 West Pharmaceutical Services Inc.
Beta (Stock Volatility) 1.07 1.15 The Cooper Companies Inc.
Short % of Float 3.81% 4.38% The Cooper Companies Inc.

The Cooper Companies Inc. vs West Pharmaceutical Services Inc. Stock Performance Analysis

Loading Price Chart...

COO
WST

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
The Cooper Companies Inc.-0.18%1.45%13.67%-4.62%-16.89%-16.46%
West Pharmaceutical Services Inc.0.79%3.65%9.42%37.92%21.91%19.91%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
The Cooper Companies Inc.-2.61%-26.10%-29.28%67.73%272.56%504.45%
West Pharmaceutical Services Inc.48.18%-9.18%-6.66%345.01%1,441.58%1,794.12%

Performance & Financial Health Analysis: The Cooper Companies Inc. vs West Pharmaceutical Services Inc.

MetricCOOWST
Market Information
Market Cap i$12.67B$22.07B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,772,7821,085,830
90 Day Avg. Volume i1,946,877930,327
Last Close$67.76$331.43
52 Week Range$58.89 - $89.83$206.80 - $336.82
% from 52W High-24.57%-1.60%
All-Time High$115.90 (Aug 30, 2021)$475.35 (Sep 06, 2021)
% from All-Time High-41.54%-30.28%
Growth Metrics
Quarterly Revenue Growth0.06%0.21%
Quarterly Earnings Growth0.25%0.55%
Financial Health
Profit Margin (TTM) i0.10%0.17%
Operating Margin (TTM) i0.21%0.22%
Return on Equity (TTM) i0.05%0.19%
Debt to Equity (MRQ) i33.2010.73
Cash & Liquidity
Book Value per Share (MRQ)$42.87$44.11
Cash per Share (MRQ)$0.64$7.38
Operating Cash Flow (TTM) i$866.40M$715.30M
Levered Free Cash Flow (TTM) i$367.09M$275.66M
Dividends
Last 12-Month Dividend Yield iN/A0.46%
Last 12-Month Dividend i$0.00$1.07

Valuation & Enterprise Metrics Analysis: The Cooper Companies Inc. vs West Pharmaceutical Services Inc.

MetricCOO (Apr 24, 2026)WST (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i33.4840.99
Forward P/E i13.4132.05
PEG Ratio i1.180.74
Price to Sales (TTM) i3.166.72
Price to Book (MRQ) i1.576.94
Market Capitalization
Market Capitalization i$12.67B$22.07B
Enterprise Value i$15.78B$21.43B
Enterprise Value Metrics
Enterprise to Revenue i3.806.65
Enterprise to EBITDA i14.3624.63
Risk & Other Metrics
Beta i1.071.15
Book Value per Share (MRQ) i$42.87$44.11

Financial Statements Comparison: The Cooper Companies Inc. vs West Pharmaceutical Services Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricCOO (2025)WST (2025)
Revenue/Sales i4.09B3.07B
Cost of Goods Sold i1.41B1.97B
COGS % of Revenue i34.5%64.1%
Gross Profit i2.68B1.10B
Gross Margin i65.5%35.9%
Research & Development i172.20M74.30M
Operating Income (EBIT) i682.90M636.10M
Operating Margin i16.7%20.7%
EBITDA i1.05B822.70M
EBITDA Margin i25.7%26.8%
Pre-Tax Income i566.50M600.90M
Pre-Tax Income % of Revenue i13.8%19.5%
Income Tax i191.60M121.60M
Income Tax % of Revenue i4.7%4.0%
Net Income (Profit) i374.90M493.70M
Profit Margin i9.2%16.1%

Balance Sheet & Liquidity Metrics

MetricCOO (2025)WST (2025)
Cash & Equivalents i110.60M791.30M
Total Current Assets i2.11B1.98B
Total Current Assets % of Revenue i51.5%64.4%
Total Current Liabilities i1.11B654.90M
Total Current Liabilities % of Revenue i27.2%21.3%
Long-Term Debt i2.46B298.40M
Long-Term Debt % of Revenue i60.1%9.7%
Total Shareholders Equity i8.24B3.18B
Retained Earnings i7.64B4.37B
Retained Earnings % of Revenue i186.8%142.3%
Property, Plant & Equipment i2.10M296.40M

Cash Flow Statement Comparison

MetricCOO (2025)WST (2025)
Operating Cash Flow i742.60M753.00M
Operating Cash Flow % of Revenue i18.1%24.5%
Capital Expenditures i-362.40MN/A
Free Cash Flow i433.70M468.90M
FCF Margin i10.6%15.3%
Debt Repayment i-3.21B-1.10M
Common Stock Repurchase i-290.10M-136.80M

Short Interest & Institutional Ownership Analysis

MetricCOOWST
Shares Short i6.53M2.66M
Short Ratio i3.193.18
Short % of Float i3.81%4.38%
Shares Outstanding i195.10M70.90M
Float Shares i193.68M70.15M
% Held by Insiders i0.62%0.64%
% Held by Institutions i105.72%99.21%
% Held by Public i-6.34%0.15%

Dividend Analysis & Yield Comparison: The Cooper Companies Inc. vs West Pharmaceutical Services Inc.

MetricCOOWST
Last 12-Month Dividend i$0.00$1.07
Last 12-Month Dividend Yield iN/A0.46%
3-Year Avg Annual Dividend i$0.01$0.82
3-Year Avg Dividend Yield i0.01%0.07%
3-Year Total Dividends i$0.03$2.46
Ex-Dividend DateJul 26, 2023Jan 28, 2026